Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report

被引：1
|
作者：
Streicher, Caroline [1 ]
Engalenc, Xavier [2 ]
Gaudin, Marion [2 ]
Vignaud, Guillaume [2 ]
Daulange, Annick [1 ]
Abraham, Bruno [2 ]
机构：
[1] Ctr Hosp Brive La Gaillarde, Unite Preparat Controle Pharmaceut, 1 Blvd Dr Verlhac, F-19312 Brive La Gaillarde, France
[2] Ctr Hosp Brive La Gaillarde, Med Interne Malad Infect, 1 Blvd Dr Verlhac, F-19312 Brive La Gaillarde, France
来源：
CLINICAL DRUG INVESTIGATION | 2020年 / 40卷 / 11期
关键词：
D O I：
10.1007/s40261-020-00969-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1085 / 1088
页数：4
相关论文
共 50 条
  • [1] Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report
    Caroline Streicher
    Xavier Engalenc
    Marion Gaudin
    Guillaume Vignaud
    Annick Daulange
    Bruno Abraham
    [J]. Clinical Drug Investigation, 2020, 40 : 1085 - 1088
  • [2] Tocilizumab could reduce Mortality in severe COVID-19
    Ruchalla, Elke
    [J]. PNEUMOLOGIE, 2021, 75 (05):
  • [3] Tocilizumab in HIV patient with severe COVID-19: case report
    Pedro Vieira Bertozzi
    Amanda de Oliveira Vicente
    Amanda Siqueira Pereira
    Joao Pedro Espinha de Sant’Ana
    Rafaela Braga Cabrera Mano
    Luciana Souza Jorge
    Rodrigo Afonso da Silva Sardenberg
    [J]. AIDS Research and Therapy, 18
  • [4] Tocilizumab in HIV patient with severe COVID-19: case report
    Bertozzi, Pedro Vieira
    Vicente, Amanda de Oliveira
    Pereira, Amanda Siqueira
    Espinha de Sant'Ana, Joao Pedro
    Cabrera Mano, Rafaela Braga
    Jorge, Luciana Souza
    da Silva Sardenberg, Rodrigo Afonso
    [J]. AIDS RESEARCH AND THERAPY, 2021, 18 (01):
  • [5] THERAPEUTIC OUTCOMES FOLLOWING TOCILIZUMAB ADMINISTRATION IN PATIENTS WITH SEVERE COVID-19
    Kline, Jonathan
    Patel, Payal
    Palma, Stephanie
    Pasqualicchio, Michael
    Clarke, Heidi
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 84 - 84
  • [6] Why tocilizumab could be an effective treatment for severe COVID-19?
    Binqing Fu
    Xiaoling Xu
    Haiming Wei
    [J]. Journal of Translational Medicine, 18
  • [7] Why tocilizumab could be an effective treatment for severe COVID-19?
    Fu, Binqing
    Xu, Xiaoling
    Wei, Haiming
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [8] Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report
    Xu, C. -Y.
    Lu, S. -D.
    Ye, X.
    Cao, M. -Y.
    Xu, G. -D.
    Yu, Q.
    Qian, J. -X.
    Zeng, G.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (08) : 569 - 572
  • [9] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [10] Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection - Case Series Report
    Fu, Chunlan
    Zhu, Yuanyuan
    Huang, Weijia
    Luo, Yi
    Hu, Yongxian
    Huang, He
    Sun, Jie
    [J]. INFECTION AND DRUG RESISTANCE, 2024, 17 : 31 - 39
12345